
Akerna Corp. KERN
Quarterly report 2025-Q3
added 11-14-2025
Akerna Corp. Operating Income 2011-2026 | KERN
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Akerna Corp.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.7 M | -19.2 M | -43.1 M | -33.4 M | -17.3 M | -12.5 M | -2.46 M | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -2.46 M | -43.1 M | -20.8 M |
Quarterly Operating Income Akerna Corp.
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.2 M | -2.23 M | -5.47 M | - | -10.2 M | -5.87 M | -1.56 M | - | -9.2 M | -2.68 M | -1.93 M | - | -3.71 M | -20.2 M | -19.9 M | - | -3.72 M | -6.05 M | -3.51 M | - | -5.52 M | -6.18 M | -5.52 M | -4.39 M | -2.4 M | -7.31 M | -2.92 M | -2.45 M | -1.71 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 7.2 M | -20.2 M | -5.31 M |
Operating Income of other stocks in the Health information services industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Cerner Corporation
CERN
|
708 M | - | - | $ 27.9 B | ||
|
Accolade
ACCD
|
-46.8 M | - | 0.29 % | $ 206 M | ||
|
Computer Programs and Systems
CPSI
|
-42.6 M | - | 4.4 % | $ 133 M | ||
|
Covetrus
CVET
|
-23 M | - | - | $ 2.94 B | ||
|
iCAD
ICAD
|
-6.27 M | - | - | $ 102 M | ||
|
Allscripts Healthcare Solutions
MDRX
|
77.2 M | - | -10.39 % | $ 886 M | ||
|
MTBC
MTBC
|
9.12 M | - | -0.58 % | $ 51.7 M | ||
|
1Life Healthcare
ONEM
|
-243 M | - | - | $ 3.37 B | ||
|
HealthStream
HSTM
|
21.3 M | $ 22.03 | 1.52 % | $ 669 M | ||
|
Premier
PINC
|
1.12 M | - | - | $ 2.33 B | ||
|
R1 RCM
RCM
|
146 M | - | - | $ 3.81 B | ||
|
American Well Corporation
AMWL
|
-105 M | $ 5.56 | 7.96 % | $ 89.2 M | ||
|
Evolent Health
EVH
|
3.64 M | $ 3.55 | 1.28 % | $ 333 M | ||
|
HealthEquity
HQY
|
118 M | $ 81.45 | 1.27 % | $ 6.97 B | ||
|
Change Healthcare
CHNG
|
137 M | - | - | $ 9.03 B | ||
|
Omnicell
OMCL
|
337 K | $ 41.51 | 1.73 % | $ 1.91 B | ||
|
GoodRx Holdings
GDRX
|
65.8 M | $ 2.19 | 5.8 % | $ 845 M | ||
|
Progyny
PGNY
|
15.8 M | $ 17.95 | 2.43 % | $ 1.54 B | ||
|
Health Catalyst
HCAT
|
-69.8 M | $ 1.94 | 12.79 % | $ 117 M | ||
|
Schrödinger
SDGR
|
-167 M | $ 13.17 | 5.32 % | $ 967 M | ||
|
Teladoc Health
TDOC
|
-263 M | $ 5.2 | 1.76 % | $ 916 M | ||
|
So-Young International
SY
|
-624 M | $ 2.89 | 3.96 % | $ 229 M | ||
|
10x Genomics
TXG
|
-265 M | $ 22.46 | -0.73 % | $ 2.63 B | ||
|
SCWorx Corp.
WORX
|
-1.26 M | $ 0.14 | -19.22 % | $ 204 K | ||
|
NantHealth
NH
|
-51.3 M | - | -46.64 % | $ 10.4 M | ||
|
OptimizeRx Corporation
OPRX
|
-26.4 M | $ 7.94 | 8.47 % | $ 136 M | ||
|
NextGen Healthcare
NXGN
|
12.8 M | - | - | $ 1.6 B | ||
|
Veeva Systems
VEEV
|
429 M | $ 188.53 | 1.38 % | $ 30.3 B | ||
|
Phreesia
PHR
|
-136 M | $ 12.67 | 2.34 % | $ 691 M | ||
|
Zhongchao
ZCMD
|
-341 K | $ 1.69 | -1.98 % | $ 8.8 M | ||
|
Signify Health
SGFY
|
9.5 M | - | -0.02 % | $ 7.21 B | ||
|
Streamline Health Solutions
STRM
|
-8.03 M | - | - | $ 21.4 M | ||
|
Tabula Rasa HealthCare
TRHC
|
-69 M | - | - | $ 255 M |